Runsheng Pharmaceutical

Runsheng Pharmaceutical is a specialized pharmaceutical company focused on the development and manufacturing of high-end inhalation drug delivery systems for respiratory diseases. Based in Chongqing, China, the company integrates R&D, clinical development, and large-scale GMP manufacturing for complex generics and innovative inhaled therapies. Their core expertise lies in Dry Powder Inhalers (DPI) and Metered Dose Inhalers (MDI), targeting global markets including China, the US, and Europe. The company's lead programs include generic versions of blockbuster respiratory treatments like Advair and Spiriva. Runsheng aims to provide high-quality, affordable respiratory medicines through its proprietary device and formulation platforms.